Symbol="CYCCP"
AssetType="Preferred Stock"
Name="Cyclacel Pharmaceuticals Inc"
Description="Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey."
CIK="1130166"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="33066600"
EBITDA="-28529000"
PERatio="None"
PEGRatio="0"
BookValue="0.406"
DividendPerShare="0"
DividendYield="0.0345"
EPS="-2.047"
RevenuePerShareTTM="0.03"
ProfitMargin="0"
OperatingMarginTTM="-76.57"
ReturnOnAssetsTTM="-0.689"
ReturnOnEquityTTM="-1.345"
RevenueTTM="373000"
GrossProfitTTM="-455000"
DilutedEPSTTM="-2.047"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-"
Beta="1.078"
num_52WeekHigh="22.12"
num_52WeekLow="5.87"
num_50DayMovingAverage="14.34"
num_200DayMovingAverage="12.98"
SharesOutstanding="12497400"
DividendDate="2023-08-01"
ExDividendDate="2023-07-20"
symbol="CYCCP"
open="17.45"
high="17.45"
low="17.39"
price="17.39"
volume="1785.00"
latest_trading_day="2023-08-18"
previous_close="17.45"
change="-0.06"
change_percent="-0.3438%"
aroon_positive_momentum_days="43"
aroon_negative_momentum_days="0"
trend_strength="Strong Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="43"
Volume_recent_avg="2347"
Change_recent_avg="0.01"
Delta_recent_avg="0.88"
Variance_recent_avg="0.44"
Change_ratio_recent_avg="-0.02"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_10"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="43"
Aroon_momentum_negative="57"
image_negative_thumbnail_id_1="1133"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0166.jpeg"
image_negative_thumbnail_id_2="1088"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0121.jpeg"
image_neutral_thumbnail_id_1="546"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_neutral_thumbnail_id_2="564"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_positive_thumbnail_id_1="982"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0144.jpeg"
image_positive_thumbnail_id_2="654"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0054.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
